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Reduction of lymphoid tissue by splenectomy and/or 
thymectomy has been used as a part of immunosuppression in 
organ transplantation (4). More recently Walker (7), Johnson 
(2), Franksson (1) and Starzl (5,6) and their associates 
have shown that chronic depletion of lymphocytes by thoracic 
duct drainage decreases the incidence of rejection and hence 
increases renal graft survival. 
Mechanical removal of lymphocytes from circulation 
peripheral blood should theoretically achieve the same or 
similar effect on the immunity as thoracic duct drainage. 
Since September, 1979, five organ transplant recipients have 
received multiple lymphocytapheresis by fB~1 2997 Blood_Cell 
Separator as a mechanical pretransplant ir.IfTiunosuppression. 
The changes in cellular and humoral immunity and the clinical 
outcome are presented in this report. 
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r"lATERIAL AND HETHOD 
Case fviaterial 
Four patients with end state liver disease and one with 
end stage renal disease received lymphapheresis three to six 
times a week prior to transplantation. Sex, age and original 
disease are listed in Table 1. All four liver patients had 
massive ascites and, therefore, they were unsuitable for 
thoracic duct drainage prior to transplantation. One kidney 
patient had had an unsuccessful thoracic duct drainage 
before he v,as chosen for lymphocytapheres is. 
Vascular Access 
External arterio-venous shunt was created for liver 
patients using the posterior tibial artery and great saphenous 
vein at the ankle level. Arterio-venous fistula of the 
forearm for hemodialysis was used for a kidney patient. 
Lymphapheresis 
IBf1 2997 Blood Cell Separator \'Jas used for lymphocytapheresi s. 
Four thousand to 6,000 units of heparin were given intravenously 
prior to lymphocytapheresis and 100 to 300 units/min. of heparin 
were infused regionally throughout the procedure. On some 
occasions 2-3 ml/min. of ACO-A solution were also infused to 
prevent the blockage of the WBC line. The blood was processed 
at the rate of 80 ml/min. and centrifuged at 1150 rpm. Buffy 
coat was collected at the rate of 2-3 ml/min. through the UBC 
line. Each lymphocytapheresis lasted for 60 to 120 minutes, 
processing 5,UOO to 11,UOU ml of blood. 
Inmunological Monitoring 
Peripheral lymphocytes were counted before and after 
each apheresis and the total number of leukocytes and lympho-
cytes removed by pheresis were measured each time. Peripheral 
lymphocyte activity was studied by PHA stimulation and also 
humoral immunity by ADCC by the method described by Sasaki 
et a 1 (3). 
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TABLE 1. 
Age, sex and Original Disease of Five Patients Who 
Received Long Term Lymphocytapheresis 
Case Age Sex Origi nal Disease qrans~lant 
1 33 ~lal e Primary biliary cirrhosis Liver 
2 32 Female Chronic active hepatitis liver 
3 27 Female Chronic active hepatitis Liver 
4 36 Female Secondary biliary cirrhosis Liver 
5 42 ~lale End-stage renal disease (?CGN) Renal 
RESULTS 
A. Lymphocytapheresis 
Each procedure lasted 60 to 120 minutes and 4,000 to 
1U,OUU m1 of blood was processed each time. Sixteen to 42 
aphereses were performed during the period of 21 to 52 days. 
The total number of lymphocytes removed by a series of 
aphereses prior to transplant ranged from 14.0 x 10 9 to 
103.7 x 109, IISC (including lymphocytes) ranged from J.8.2 x 
10 9 to 376 x 109, and lymphocyte-rich plasma from 3629 to 
9839 ml in five cases (Table 2). 
TABLE 2. 
Total Number of Lymphocytes, WBC and Plasma 
Removed by Lymphocytapheresis 
Period 
riumber of Lymphocytes \JBC Plasma 
of Apheresis 
A~heresis {aa~s~ {x10 9 ~ {x1M9~ {ml ~ 
Case 1. 22 30 69.1 83.6 3629 
Case 2. 21 35 25.5 39.0 4192 
Case 3. 16 21 14.0 18.2 4424 
Case 4. 35 52 103.7 376.0 7514 
Case 5. 42 52 93.5 146.2 9839 
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The mean number of lymphocytes, WBC, and platelets 
removed by a single lymphocytapheresis are summarized in 
Table 3; lymphocytes ranged from 0.9 x 10 9 to 3.5 X 10 9, WBC 
from 1.1 x 109 to 10.7 X 109, platelets from 10.5 x 10 6 to 
122.6 X 109 and lymphocyte-rich plasma 189 to 275 ml. 
TABLE 3. Mean Number of Lymphocytes, WBC, Platelets and 
Plasma 
Removed by Each Lymphocytapheresis 
Lymphocytes WBC Platelet Plasma 
(XI09} (xl09} {x10 6 } (011 } 
Case 1. 3.5 ± 2.0 4.5 ± 2.6 144.0 ± 14.3 189 ± 46 
Case 2. 1.3 ± 0.7 2.0 ± 1.2 83.7 ± 11.3 196 ± 32 
Case 3. 0.9 ± 0.4 1.1 ± 0.4 10.5 ± 1.7 275 ± 45 
Case 4. 2.9 ± 3.6 10.7 ± 15.1 78.2 ± 10.0 208 ± 40 
Case 5. 2.1 ± 1.5 3.5 ± 2.0 122.6 ± 9.9 239 ± 39 
The mean changes in peripheral blood, WBC, lymphocytes, 
platelet count and hematocrit by a single lymphocytapheresis 
are summarized in Table 4; ~gBC and lymphocyte count decreased 
significantly in three of five cases (p < 0.05); the platelet 
count decreased in all five cases, and the hematocrit in 
four of five cases. 
TABLE 4 
Mean Changes in Peripheral Blood WBC, Lymphocytes, Platelet 
Count and Hematocrit Before and After Lymphocytapheresis 
WBC Lymphocytes Platelet 
{Lmm 3 } {Lmm3 } (xl03/mm 3} Hematocrit {%} 
Case 1. -730(-10%} -180(-7%} -16(-10%} -3.2(-12%} 
p<0.1 n.s p<O.Ol p<O.OOI 
Case 2. -2500(-17%} -300(-37%) -33(-26%} -3.8(-17%} 
p< O. 01 p<0.05 p<O.OOl p<O.OOl 
Case 3. -500(-12%) -100(-14%) -13(-21%) -3.6(-13%} 
n.s p<0.1 p<O.OOl n.s 
Case 4. -2400(-16%) -500(-45%) -65(-13%} -3.4(-13%) 
p< 0.001 p<0.001 p<O.OOl p<O.OOl 
Case 5. -600(-7%} -200(-15%) -87(-35%) -2.8{-12%} 
p< 0.05 p<0.01 p<0.001 p<0.001 
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By a series of aphereses, peripheral blood WBC count 
decreased significantly in one of five cases (Case 3). The 
lymphocyte count decreased in four of five cases (Cases 2, 
3, 4, and 5). The platelet count decreased slightly in all 
of the five cases, and the hematocrit decreased also in all 
cases. In four of five cases, blood transfusion was necessary 
to improve the general condition of the patients. 
B. Immunological Changes 
Cellular immunity measured by PHA stimulation index (3) 
decreased significantly by a series of lymphocytapheresis in 
three of five cases (Cases 1, 2, and 4). Humoral immunity 
monitored by ADCC (3) decreased in three of five cases 
(Cases 2, 3, and 4). A strong antimitochondrial antibody 
present in Case 1 completely disappeared after a series of 
lymphocytaphereses. 
C. Results of Transplant 
THO of the four liver transplant recipients are alive 
and well (Cases 3 and 4), without any evidence of graft 
rejection. One liver recipient (Case 1) died after 10 days 
because of a poorly functioning graft and another recipient 
died of pulmonary sepsis after three weeks. 
One kidney recipient is doing y~ell with normal renal 
function in the third post-transplantation month. 
Figures 1 and 2 illustrate the changes in peripheral 
blood counts and immunity by a series of lymphocytaphereses. 
DISCUSSION 
The number of lymphocytes removed by lymphocytapheresis 
largely depends upon the lymphocyte count and the hematocrit 
of pheripheral blood. Peripheral blood lymphocyte count of 
less than RMM/~1 in the presence of hypersplenism and the 
hematocrit of less than 20% make the yield of lymphocytapheresis 
minimal. The clumping of leukocytes and platelets in the 
centrifuge and in the tubing system can occasionally become 
a problem with heparin anticoagulation. Additional ACD-A 
anticoagulant does not always solve this problem. Improvement 
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Figure 1. Case 1 is a 33-year-old male with primary biliary 
cirrhosis. The PHA stimulation index decreased rapidly by a 
series of lymphocytaphereses. Antimitochondrial antibody (ANA) 
disappeared after a three-week course of lymphocytapheresis. 
of the tubing material, such as the Teflon coating of tubes 
and filters, may be helpful. Heparin seems to be better 
tolerated by the cirrhotics and the uremics than citrate 
anticoagulation. Fluid balance is very important for these 
patients, as fluid overload with priming saline to minimize 
the red cells and protein loss should be avoided. 
Cellular immunity monitored by PHA stimulation and/or 
humoral immunity by ADCC decreased in four of five cases. 
These immunological alterations correlate with the numbers 
of lymphocytes removed by lymphocytapheresis on an individual 
basis. However, adequate immunosuppression was achieved by 
a relatively small amount of lymphocytapheresis in Cases 2 
and 3. No effect was observed in Case 5 in spite of a large 
amount of lymphocytapheresis. A decrease in peripheral blood 
lymphocyte count did not always correlate with immunological 
suppression monitored Hith PHA stimulation and ADCC. 
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Figure 2. Case 4 is that of a 36-year-old female with 
secondary biliary cirrhosis. The PHA stimulation index and 
AOCC (% cystolysis) decreased rapidly by lymphocytapheresis. 
( i- indicates blood transfusion). 
Our limited clinical experience and primitive immuno-
logical studies in the five cases seem to indicate that 
lymphocytapheresis decreases cellular and humoral immunity 
and prevents rejection in organ transplant recipients. 
Detailed immunological analyses are being undertaken at 
present. 
The disappearance of the antimitochondrial antibodies 
in Case 1 during lymphocytaphereses needs to be confirmed. 
Additional patients with primary biliary cirrhosis are now 
planned for lymphocytapheresis. The clinical significance 
of removing the antimitochondrial antibodies in these patients 
can only be discussed when more substantial data are available. 
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